Process for preparing dazoline phospho acid
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- YANGTZE RIVER PHARM GRP CO LTD
- Publication Date
- 2005-11-09
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
technical field
[0001] The invention relates to a preparation method for one-step synthesis of zoledronic acid by using imidazole as a starting material. Background technique
[0002] Zoledronic acid, whose chemical name is [1-hydroxy-2-(1-imidazolyl) ethylidene] diphosphate monohydrate, is a heterocyclic third-generation bisphosphonic acid drug for the treatment of hypercalcemia. The drug can reduce the incidence of bone and soft tissue metastasis in cancer patients. It can be used as an adjuvant treatment for cancer patients with bone metastasis to relieve hypercalcemia, bone pain and the risk of fractures. It can also be used to delay the occurrence of bone metastasis. Its mechanism of action is to inhibit bone metastasis. Absorption reduces the release of bone matrix growth factors or inhibits cancer cells from adhering to the bone matrix. Clinical trials have shown that this product is the strongest bisphosphonate compound so far. In 2000, zoledronic acid was first ap...